LUKKA, INC. – Trademark Portfolio
Entity Type: 03
LUKKA, INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 4 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include LUKKA, COINFIRM, and TRUDATUM. The owner is based in NEW YORK, NY.
130 FIFTH AVENUE, 3RD FLOOR
NEW YORK, NY 10011
Showing of trademarks Trademarks
Trademark Classifications
LUKKA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LUKKA, INC. have?
LUKKA, INC. has 12 U.S. trademarks filed with the USPTO. Of these, 8 registered, 4 abandoned.
What trademark classes does LUKKA, INC. file in?
LUKKA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LUKKA, INC.'s most well-known trademarks?
LUKKA, INC.'s registered trademark portfolio includes well-known marks such as LUKKA, COINFIRM, and TRUDATUM. These are among 8 currently registered trademarks in the portfolio.
What is LUKKA, INC.'s trademark registration success rate?
LUKKA, INC. has a 67% trademark registration rate, with 8 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.